Environmental Epidemiology

A growing number of chemical and physical agents have been classified as carcinogens by the World Health Organization’s International Agency for Research on Cancer and the National Institute of Environmental Health Sciences’ National Toxicology Program. EGRP is committed to supporting the study of these agents, their contribution and effects on cancer risk, and the advancement of methodological development to improve these efforts.

EGRP aims to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life.

EGRP is interested in research that integrates biological data with epidemiological data from environmental exposure and germline genetic projects, and includes mechanistic follow-up designed to understand the biological processes involved in the interplay between environmental exposures and genes at the molecular, cellular, and/or organism level.

NCI is interested in research that integrates and analyzes geospatial data and/or spatial methodology across the cancer control continuum. Geospatial approaches include the use of location-based technologies such as geographic information systems (GIS), global positioning systems (GPS), other location-based technologies or may involve improved mapping techniques and applied spatial methodology.

EGRP supports NCI’s priorities in global health and collaborates with NCI’s Center for Global Health and NIH partners to support research for cancer control and prevention, globally.

Staff in EGRP partner with others at NCI and NIH to foster research to better understand the causes of health disparities and develop interventions to reduce differences in the incidence, prevalence, mortality, and burden of cancer and related adverse health conditions that exist among specific population groups in the United States.

EGRP partners with others at NCI and NIH to foster investigator-initiated research to better understand the role of infectious agents in cancer.

Staff in EGRP partner with others at NCI and NIH to foster analysis of the microbiome and associated metabolites that may assist in the understanding of microbial exposures and their association with disease risk, incidence, progression, and treatment response.